These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1821827)

  • 21. [Experience with botulinum toxin treatment of facial-cervical dystonias and hemifacial spasm].
    Erbguth F; Claus D; Neundörfer B
    Nervenarzt; 1990 Oct; 61(10):611-4. PubMed ID: 2274093
    [No Abstract]   [Full Text] [Related]  

  • 22. Local treatment of spasmodic torticollis with botulinum toxin.
    Tsui JK; Fross RD; Calne S; Calne DB
    Can J Neurol Sci; 1987 Aug; 14(3 Suppl):533-5. PubMed ID: 3676924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low dose botulinum toxin in spasmodic torticollis.
    D'Costa DF; Abbott RJ
    J R Soc Med; 1991 Nov; 84(11):650-1. PubMed ID: 1744868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum A toxin for the treatment of adult-onset spasmodic torticollis.
    Borodic GE; Mills L; Joseph M
    Plast Reconstr Surg; 1991 Feb; 87(2):285-9. PubMed ID: 1989021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollis.
    Gelb DJ; Lowenstein DH; Aminoff MJ
    Neurology; 1989 Jan; 39(1):80-4. PubMed ID: 2642616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Botulinum toxin, hope in the treatment of torticollis].
    Teräväinen H; Kaakkola S
    Duodecim; 1992; 108(5):440-2. PubMed ID: 1366044
    [No Abstract]   [Full Text] [Related]  

  • 27. Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis.
    Greene P; Kang U; Fahn S; Brin M; Moskowitz C; Flaster E
    Neurology; 1990 Aug; 40(8):1213-8. PubMed ID: 2199847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
    Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
    Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low dose botulinum toxin for spasmodic torticollis.
    Moore AP
    J R Soc Med; 1992 May; 85(5):304. PubMed ID: 1290538
    [No Abstract]   [Full Text] [Related]  

  • 30. Botulinum toxin for spasmodic torticollis in a patient with myasthenia gravis.
    Emmerson J
    Mov Disord; 1994 May; 9(3):367. PubMed ID: 8041381
    [No Abstract]   [Full Text] [Related]  

  • 31. A pilot study on the use of botulinum toxin in spasmodic torticollis.
    Tsui JK; Eisen A; Mak E; Carruthers J; Scott A; Calne DB
    Can J Neurol Sci; 1985 Nov; 12(4):314-6. PubMed ID: 4084867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double-blind study of botulinum toxin in spasmodic torticollis.
    Tsui JK; Eisen A; Stoessl AJ; Calne S; Calne DB
    Lancet; 1986 Aug; 2(8501):245-7. PubMed ID: 2874278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Botulin toxins in the treatment of spasmodic torticollis].
    Teixeira SC; de Alencar R; Teixeira GP
    Rev Assoc Med Bras (1992); 1995; 41(6):406-10. PubMed ID: 8733251
    [No Abstract]   [Full Text] [Related]  

  • 34. Dystonia and headaches: clinical features and response to botulinum toxin therapy.
    Galvez-Jimenez N; Lampuri C; Patiño-Picirrillo R; Hargreave MJ; Hanson MR
    Adv Neurol; 2004; 94():321-8. PubMed ID: 14509690
    [No Abstract]   [Full Text] [Related]  

  • 35. Change in pattern of muscle activity following botulinum toxin injections for torticollis.
    Gelb DJ; Yoshimura DM; Olney RK; Lowenstein DH; Aminoff MJ
    Ann Neurol; 1991 Apr; 29(4):370-6. PubMed ID: 1929208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic uses of botulinum toxin.
    Wheeler AH
    Am Fam Physician; 1997 Feb; 55(2):541-5, 548. PubMed ID: 9054223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The position of the head in space: a kinematic analysis in patients with cervical dystonia treated with botulinum toxin.
    Albani G; Bulgheroni MV; Mancini F; Mauro A; Fundarò C; Pacchetti C; Sandrini G; Nappi G
    Funct Neurol; 2001; 16(2):135-41. PubMed ID: 11495419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical symptoms, diagnosis and treatment of focal dystonias].
    Klivényi P; Vécsei L
    Orv Hetil; 2001 Oct; 142(42):2293-7. PubMed ID: 11760645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum toxin: influence on respiratory heart rate variation.
    Claus D; Druschky A; Erbguth F
    Mov Disord; 1995 Sep; 10(5):574-9. PubMed ID: 8552108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interventional neurology: botulinum toxin as a potent symptomatic treatment in neurology.
    Giladi N; Meer J; Kidan C; Greenberg E; Gross B; Honigman S
    Isr J Med Sci; 1994 Nov; 30(11):816-9. PubMed ID: 7982770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.